Gigantic business: Titin properties and function through thick and thin

Circulation Research

Volumn 114, Issue 6, 2014, Pages 1052-1068

  Linke, Wolfgang A ^a   Hamdani, Nazha ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Heart failure

Indexed keywords

CONNECTIN; ISOPROTEIN;

DIASTOLIC HEART FAILURE; ELASTICITY; HEART MUSCLE; HUMAN; HUMAN GENOME; LIGAND BINDING; MOLECULAR DYNAMICS; MUSCLE RIGIDITY; MYOCARDIAL DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SARCOMERE;

HEART FAILURE;

ANIMALS; COMPLIANCE; CONNECTIN; DIASTOLE; DISEASE MODELS, ANIMAL; ELASTICITY; HEART DISEASES; HEART FAILURE; HUMANS; MUSCLE, SKELETAL; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SARCOMERES; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; VASCULAR STIFFNESS;

EID: 84897874678     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.114.301286     Document Type: Review

References (156)

1. Gautel M. The sarcomeric cytoskeleton: who picks up the strain? Curr Opin Cell Biol. 2011;23:39-46.
2. Tskhovrebova L, Trinick J. Roles of titin in the structure and elasticity of the sarcomere. J Biomed Biotechnol. 2010;2010:612482.
3. Linke WA. Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. Cardiovasc Res. 2008;77:637-648.
4. Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial infammation. J Am Coll Cardiol. 2013;62:263-271.
5. Paulus WJ, van Ballegoij JJ. Treatment of heart failure with normal ejection fraction: an inconvenient truth! J Am Coll Cardiol. 2010;55:526-537.
6. van Heerebeek L, Borbély A, Niessen HW, Bronzwaer JG, van der Velden J, Stienen GJ, Linke WA, Laarman GJ, Paulus WJ. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation. 2006;113:1966-1973.
7. Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinas-es: infuence on cardiac form and function. Physiol Rev. 2007;87:1285-1342.
8. Linke WA, Popov VI, Pollack GH. Passive and active tension in single cardiac myofbrils. Biophys J. 1994;67:782-792.
9. Granzier HL, Irving TC. Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate flaments. Biophys J. 1995;68:1027-1044.
10. LeWinter MM, Wu Y, Labeit S, Granzier H. Cardiac titin: structure, functions and role in disease. Clin Chim Acta. 2007;375:1-9.
11. Bang ML, Centner T, Fornoff F, Geach AJ, Gotthardt M, McNabb M, Witt CC, Labeit D, Gregorio CC, Granzier H, Labeit S. The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. Circ Res. 2001;89:1065-1072.
12. Fürst DO, Osborn M, Nave R, Weber K. The organization of titin flaments in the half-sarcomere revealed by monoclonal antibodies in immunoelec-tron microscopy: a map of ten nonrepetitive epitopes starting at the Z line extends close to the M line. J Cell Biol. 1988;106:1563-1572.
13. Freiburg A, Trombitas K, Hell W, Cazorla O, Fougerousse F, Centner T, Kolmerer B, Witt C, Beckmann JS, Gregorio CC, Granzier H, Labeit S. Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofbrillar elastic diversity. Circ Res. 2000;86:1114-1121.
14. Labeit S, Gautel M, Lakey A, Trinick J. Towards a molecular understanding of titin. EMBO J. 1992;11:1711-1716.
15. Gautel M. Cytoskeletal protein kinases: titin and its relations in mechano-sensing. Pfugers Arch. 2011;462:119-134.
16. Linke WA, Ivemeyer M, Olivieri N, Kolmerer B, Rüegg JC, Labeit S. Towards a molecular understanding of the elasticity of titin. J Mol Biol. 1996;261:62-71.
17. Trombitás K, Greaser M, Labeit S, Jin JP, Kellermayer M, Helmes M, Granzier H. Titin extensibility in situ: entropic elasticity of permanently folded and permanently unfolded molecular segments. J Cell Biol. 1998;140:853-859.
18. Linke WA, Rudy DE, Centner T, Gautel M, Witt C, Labeit S, Gregorio CC. I-band titin in cardiac muscle is a three-element molecular spring and is critical for maintaining thin flament structure. J Cell Biol. 1999;146:631-644.
19. Minajeva A, Kulke M, Fernandez JM, Linke WA. Unfolding of titin domains explains the viscoelastic behavior of skeletal myofbrils. Biophys J. 2001;80:1442-1451.
20. Li H, Linke WA, Oberhauser AF, Carrion-Vazquez M, Kerkvliet JG, Lu H, Marszalek PE, Fernandez JM. Reverse engineering of the giant muscle protein titin. Nature. 2002;418:998-1002.
21. Nedrud J, Labeit S, Gotthardt M, Granzier H. Mechanics on myocardium defcient in the N2B region of titin: the cardiac-unique spring element improves effciency of the cardiac cycle. Biophys J. 2011;101:1385-1392.
22. Radke MH, Peng J, Wu Y, McNabb M, Nelson OL, Granzier H, Gotthardt M. Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophy. Proc Natl Acad Sci USA. 2007;104:3444-3449.
23. Granzier HL, Radke MH, Peng J, Westermann D, Nelson OL, Rost K, King NM, Yu Q, Tschöpe C, McNabb M, Larson DF, Labeit S, Gotthardt M. Truncation of titin's elastic PEVK region leads to cardiomyopathy with diastolic dysfunction. Circ Res. 2009;105:557-564.
24. Chung CS, Hutchinson KR, Methawasin M, Saripalli C, Smith JE 3rd, Hidalgo CG, Luo X, Labeit S, Guo C, Granzier HL. Shortening of the elastic tandem immunoglobulin segment of titin leads to diastolic dysfunction. Circulation. 2013;128:19-28.
25. Hsin J, Strümpfer J, Lee EH, Schulten K. Molecular origin of the hierarchical elasticity of titin: simulation, experiment, and theory. Annu Rev Biophys. 2011;40:187-203.
26. Linke WA, Ivemeyer M, Mundel P, Stockmeier MR, Kolmerer B. Nature of PEVK-titin elasticity in skeletal muscle. Proc Natl Acad Sci USA. 1998;95:8052-8057.
27. Walther KA, Gräter F, Dougan L, Badilla CL, Berne BJ, Fernandez JM. Signatures of hydrophobic collapse in extended proteins captured with force spectroscopy. Proc Natl Acad Sci USA. 2007;104:7916-7921.
28. Huber T, Grama L, Hetényi C, Schay G, Fülöp L, Penke B, Kellermayer MS. Conformational dynamics of titin PEVK explored with FRET spec-troscopy. Biophys J. 2012;103:1480-1489.
29. Sorimachi H, Freiburg A, Kolmerer B, Ishiura S, Stier G, Gregorio CC, Labeit D, Linke WA, Suzuki K, Labeit S. Tissue-specifc expression and alpha-actinin binding properties of the Z-disc titin: implications for the nature of vertebrate Z-discs. J Mol Biol. 1997;270:688-695.
30. Young P, Ferguson C, Bañuelos S, Gautel M. Molecular structure of the sarcomeric Z-disk: two types of titin interactions lead to an asymmetrical sorting of alpha-actinin. EMBO J. 1998;17:1614-1624.
31. Kontrogianni-Konstantopoulos A, Bloch RJ. The hydrophilic domain of small ankyrin-1 interacts with the two N-terminal immunoglobulin domains of titin. J Biol Chem. 2003;278:3985-3991.
32. Mues A, van der Ven PF, Young P, Fürst DO, Gautel M. Two immunoglobulin-like domains of the Z-disc portion of titin interact in a conformation-dependent way with telethonin. FEBS Lett. 1998;428:111-114.
33. Zou P, Pinotsis N, Lange S, Song YH, Popov A, Mavridis I, Mayans OM, Gautel M, Wilmanns M. Palindromic assembly of the giant muscle protein titin in the sarcomeric Z-disk. Nature. 2006;439:229-233.
34. Ibrahim M, Siedlecka U, Buyandelger B, Harada M, Rao C, Moshkov A, Bhargava A, Schneider M, Yacoub MH, Gorelik J, Knöll R, Terracciano CM. A critical role for Telethonin in regulating t-tubule structure and function in the mammalian heart. Hum Mol Genet. 2013;22:372-383.
35. Candasamy AJ, Haworth RS, Cuello F, Ibrahim M, Aravamudhan S, Krüger M, Holt MR, Terracciano CM, Mayr M, Gautel M, Avkiran M. Phosphoregulation of the Titin-cap Protein Telethonin in Cardiac Myocytes. J Biol Chem. 2014;289:1282-1293.
36. Knöll R, Linke WA, Zou P, et al. Telethonin defciency is associated with maladaptation to biomechanical stress in the mammalian heart. Circ Res. 2011;109:758-769.
37. Tian LF, Li HY, Jin BF, Pan X, Man JH, Zhang PJ, Li WH, Liang B, Liu H, Zhao J, Gong WL, Zhou T, Zhang XM. MDM2 interacts with and down-regulates a sarcomeric protein, TCAP. Biochem Biophys Res Commun. 2006;345:355-361.
38. Witt CC, Burkart C, Labeit D, McNabb M, Wu Y, Granzier H, Labeit S. Nebulin regulates thin flament length, contractility, and Z-disk structure in vivo. EMBO J. 2006;25:3843-3855.
39. Labeit S, Lahmers S, Burkart C, Fong C, McNabb M, Witt S, Witt C, Labeit D, Granzier H. Expression of distinct classes of titin isoforms in striated and smooth muscles by alternative splicing, and their conserved interaction with flamins. J Mol Biol. 2006;362:664-681.
40. Young P, Ehler E, Gautel M. Obscurin, a giant sarcomeric Rho guanine nucleotide exchange factor protein involved in sarcomere assembly. J Cell Biol. 2001;154:123-136.
41. Linke WA, Ivemeyer M, Labeit S, Hinssen H, Rüegg JC, Gautel M. Actin-titin interaction in cardiac myofbrils: probing a physiological role. Biophys J. 1997;73:905-919.
42. Sheikh F, Raskin A, Chu PH, et al. An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice. J Clin Invest. 2008;118:3870-3880.
43. Lange S, Auerbach D, McLoughlin P, Perriard E, Schäfer BW, Perriard JC, Ehler E. Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2. J Cell Sci. 2002;115:4925-4936.
44. Miller MK, Bang ML, Witt CC, Labeit D, Trombitas C, Watanabe K, Granzier H, McElhinny AS, Gregorio CC, Labeit S. The muscle an-kyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin flament-based stress response molecules. J Mol Biol. 2003;333:951-964.
45. Kulke M, Fujita-Becker S, Rostkova E, Neagoe C, Labeit D, Manstein DJ, Gautel M, Linke WA. Interaction between PEVK-titin and actin fla-ments: origin of a viscous force component in cardiac myofbrils. Circ Res. 2001;89:874-881.
46. Yamasaki R, Berri M, Wu Y, Trombitás K, McNabb M, Kellermayer MS, Witt C, Labeit D, Labeit S, Greaser M, Granzier H. Titin-actin interaction in mouse myocardium: passive tension modulation and its regulation by calcium/S100A1. Biophys J. 2001;81:2297-2313.
47. Chung CS, Methawasin M, Nelson OL, Radke MH, Hidalgo CG, Gotthardt M, Granzier HL. Titin based viscosity in ventricular physiology: an integrative investigation of PEVK-actin interactions. J Mol Cell Cardiol. 2011;51:428-434.
48. Labeit D, Watanabe K, Witt C, Fujita H, Wu Y, Lahmers S, Funck T, Labeit S, Granzier H. Calcium-dependent molecular spring elements in the giant protein titin. Proc Natl Acad Sci USA. 2003;100:13716-13721.
49. Ma K, Forbes JG, Gutierrez-Cruz G, Wang K. Titin as a giant scaffold for integrating stress and Src homology domain 3-mediated signaling pathways: the clustering of novel overlap ligand motifs in the elastic PEVK segment. J Biol Chem. 2006;281:27539-27556.
50. Raynaud F, Astier C, Benyamin Y. Evidence for a direct but sequential binding of titin to tropomyosin and actin flaments. Biochim Biophys Acta. 2004;1700:171-178.
51. Coulis G, Becila S, Herrera-Mendez CH, Sentandreu MA, Raynaud F, Richard I, Benyamin Y, Ouali A. Calpain 1 binding capacities of the N1-line region of titin are signifcantly enhanced by physiological concentrations of calcium. Biochemistry. 2008;47:9174-9183.
52. Ojima K, Ono Y, Hata S, Koyama S, Doi N, Sorimachi H. Possible functions of p94 in connectin-mediated signaling pathways in skeletal muscle cells. J Muscle Res Cell Motil. 2005;26:409-417.
53. Duguez S, Bartoli M, Richard I. Calpain 3: a key regulator of the sarco-mere? FEBS J. 2006;273:3427-3436.
54. Ali MA, Cho WJ, Hudson B, Kassiri Z, Granzier H, Schulz R. Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury. Circulation. 2010;122:2039-2047.
55. Donlin LT, Andresen C, Just S, et al. Smyd2 controls cytoplasmic ly-sine methylation of Hsp90 and myoflament organization. Genes Dev. 2012;26:114-119.
56. Voelkel T, Andresen C, Unger A, Just S, Rottbauer W, Linke WA. Lysine methyltransferase Smyd2 regulates Hsp90-mediated protection of the sarcomeric titin springs and cardiac function. Biochim Biophys Acta. 2013;1833:812-822.
57. Bullard B, Ferguson C, Minajeva A, Leake MC, Gautel M, Labeit D, Ding L, Labeit S, Horwitz J, Leonard KR, Linke WA. Association of the chaperone alphaB-crystallin with titin in heart muscle. J Biol Chem. 2004;279:7917-7924.
58. Kötter S, Unger A, Hamdani N, Lang P, Vorgerd M, Nagel-Steger L, Linke WA. Human myocytes are protected from titin aggregation-induced stiffening by small heat shock proteins. J Cell Biol. 2014;204:187-202.
59. Zhu Y, Bogomolovas J, Labeit S, Granzier H. Single molecule force spectroscopy of the cardiac titin N2B element: effects of the molecular chaperone alphaB-crystallin with disease-causing mutations. J Biol Chem. 2009;284:13914-13923.
60. Golenhofen N, Redel A, Wawrousek EF, Drenckhahn D. Ischemia-induced increase of stiffness of alphaB-crystallin/HSPB2-defcient myocardium. Pfugers Arch. 2006;451:518-525.
61. Freiburg A, Gautel M. A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem. 1996;235:317-323.
62. Irving T, Wu Y, Bekyarova T, Farman GP, Fukuda N, Granzier H. Thick-flament strain and interflament spacing in passive muscle: effect of titin-based passive tension. Biophys J. 2011;100:1499-1508.
63. Fukuda N, Wu Y, Farman G, Irving TC, Granzier H. Titin isoform variance and length dependence of activation in skinned bovine cardiac muscle. J Physiol. 2003;553:147-154.
64. Myhre JL, Hills JA, Prill K, Wohlgemuth SL, Pilgrim DB. The titin A-band rod domain is dispensable for initial thick flament assembly in zebrafsh. Dev Biol. 2014;Epub Dec 24, 2013.
65. Weinert S, Bergmann N, Luo X, Erdmann B, Gotthardt M. M line-defcient titin causes cardiac lethality through impaired maturation of the sarco-mere. J Cell Biol. 2006;173:559-570.
66. Musa H, Meek S, Gautel M, Peddie D, Smith AJ, Peckham M. Targeted homozygous deletion of M-band titin in cardiomyocytes prevents sarco-mere formation. J Cell Sci. 2006;119:4322-4331.
67. Gregorio CC, Perry CN, McElhinny AS. Functional properties of the titin/connectin-associated proteins, the muscle-specifc RING fn-ger proteins (MURFs), in striated muscle. J Muscle Res Cell Motil. 2005;26:389-400.
68. Witt SH, Granzier H, Witt CC, Labeit S. MURF-1 and MURF-2 target a specifc subset of myofbrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination. J Mol Biol. 2005;350:713-722.
69. Lange S, Xiang F, Yakovenko A, et al. The kinase domain of titin controls muscle gene expression and protein turnover. Science. 2005;308:1599-1603.
70. Willis MS, Ike C, Li L, Wang DZ, Glass DJ, Patterson C. Muscle ring fn-ger 1, but not muscle ring fnger 2, regulates cardiac hypertrophy in vivo. Circ Res. 2007;100:456-459.
71. Mayans O, van der Ven PF, Wilm M, Mues A, Young P, Fürst DO, Wilmanns M, Gautel M. Structural basis for activation of the titin kinase domain during myofbrillogenesis. Nature. 1998;395:863-869.
72. Puchner EM, Alexandrovich A, Kho AL, Hensen U, Schäfer LV, Brandmeier B, Gräter F, Grubmüller H, Gaub HE, Gautel M. Mechanoenzymatics of titin kinase. Proc Natl Acad Sci USA. 2008;105:13385-13390.
73. Obermann WM, Gautel M, Weber K, Fürst DO. Molecular structure of the sarcomeric M band: mapping of titin and myosin binding domains in myomesin and the identifcation of a potential regulatory phosphorylation site in myomesin. EMBO J. 1997;16:211-220.
74. Agarkova I, Perriard JC. The M-band: an elastic web that crosslinks thick flaments in the center of the sarcomere. Trends Cell Biol. 2005;15:477-485.
75. Fernando P, Sandoz JS, Ding W, de Repentigny Y, Brunette S, Kelly JF, Kothary R, Megeney LA. Bin1 SRC homology 3 domain acts as a scaffold for myofber sarcomere assembly. J Biol Chem. 2009;284:27674-27686.
76. Zastrow MS, Flaherty DB, Benian GM, Wilson KL. Nuclear titin interacts with A-and B-type lamins in vitro and in vivo. J Cell Sci. 2006;119:239-249.
77. Fukuzawa A, Lange S, Holt M, Vihola A, Carmignac V, Ferreiro A, Udd B, Gautel M. Interactions with titin and myomesin target obscurin and obscurin-like 1 to the M-band: implications for hereditary myopathies. J Cell Sci. 2008;121:1841-1851.
78. Pernigo S, Fukuzawa A, Bertz M, Holt M, Rief M, Steiner RA, Gautel M. Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex. Proc Natl Acad Sci USA. 2010;107:2908-2913.
79. Sarparanta J, Blandin G, Charton K, Vihola A, Marchand S, Milic A, Hackman P, Ehler E, Richard I, Udd B. Interactions with M-band titin and calpain 3 link myospryn (CMYA5) to tibial and limb-girdle muscular dystrophies. J Biol Chem. 2010;285:30304-30315.
80. Udd B, Haravuori H, Kalimo H, Partanen J, Pulkkinen L, Paetau A, Peltonen L, Somer H. Tibial muscular dystrophy-from clinical description to linkage on chromosome 2q31. Neuromuscul Disord. 1998;8:327-332.
81. Siu BL, Niimura H, Osborne JA, Fatkin D, MacRae C, Solomon S, Benson DW, Seidman JG, Seidman CE. Familial dilated cardiomyopathy locus maps to chromosome 2q31. Circulation. 1999;99:1022-1026.
82. Satoh M, Takahashi M, Sakamoto T, Hiroe M, Marumo F, Kimura A. Structural analysis of the titin gene in hypertrophic cardiomyopathy: identifcation of a novel disease gene. Biochem Biophys Res Commun. 1999;262:411-417.
83. Itoh-Satoh M, Hayashi T, Nishi H, Koga Y, Arimura T, Koyanagi T, Takahashi M, Hohda S, Ueda K, Nouchi T, Hiroe M, Marumo F, Imaizumi T, Yasunami M, Kimura A. Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem Biophys Res Commun. 2002;291:385-393.
84. Gerull B, Gramlich M, Atherton J, McNabb M, Trombitás K, Sasse-Klaassen S, Seidman JG, Seidman C, Granzier H, Labeit S, Frenneaux M, Thierfelder L. Mutations of TTN, encoding the giant muscle flament titin, cause familial dilated cardiomyopathy. Nat Genet. 2002;30:201-204.
85. Haravuori H, Vihola A, Straub V, Auranen M, Richard I, Marchand S, Voit T, Labeit S, Somer H, Peltonen L, Beckmann JS, Udd B. Secondary cal-pain3 defciency in 2q-linked muscular dystrophy: titin is the candidate gene. Neurology. 2001;56:869-877.
86. Hackman P, Vihola A, Haravuori H, Marchand S, Sarparanta J, De Seze J, Labeit S, Witt C, Peltonen L, Richard I, Udd B. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet. 2002;71:492-500.
87. Van den Bergh PY, Bouquiaux O, Verellen C, Marchand S, Richard I, Hackman P, Udd B. Tibial muscular dystrophy in a Belgian family. Ann Neurol. 2003;54:248-251.
88. Hedberg C, Melberg A, Dahlbom K, Oldfors A. Hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain [Epub November 14, 2013]. Brain. doi:10.1093/brain/awt305. http://brain. oxfordjournals.org/content/early/2013/11/14/brain.awt305.extract. Accessed February 27, 2014.
89. Pfeffer G, Griffn H, Pyle A, Horvath R, Chinnery PF. Reply: Hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain [Epub November 21, 2013]. Brain. doi:10.1093/brain/awt306. http://brain.oxfordjournals.org/content/early/2013/11/21/brain. awt306.full.pdf. Accessed February 27, 2014.
90. Herman DS, Lam L, Taylor MR, et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012;366:619-628.
91. Chauveau C, Bonnemann CG, Julien C, et al. Recessive TTN truncating mutations defne novel forms of core myopathy with heart disease. Hum Mol Genet. 2014;23:980-991.
92. Roncarati R, Viviani Anselmi C, Krawitz P, Lattanzi G, von Kodolitsch Y, Perrot A, di Pasquale E, Papa L, Portararo P, Columbaro M, Forni A, Faggian G, Condorelli G, Robinson PN. Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy. Eur J Hum Genet. 2013;21:1105-1111.
93. Yoskovitz G, Peled Y, Gramlich M, Lahat H, Resnik-Wolf H, Feinberg MS, Afek A, Pras E, Arad M, Gerull B, Freimark D. A novel titin mutation in adult-onset familial dilated cardiomyopathy. Am J Cardiol. 2012;109:1644-1650.
94. Gerull B, Atherton J, Geupel A, Sasse-Klaassen S, Heuser A, Frenneaux M, McNabb M, Granzier H, Labeit S, Thierfelder L. Identifcation of a novel frameshift mutation in the giant muscle flament titin in a large Australian family with dilated cardiomyopathy. J Mol Med (Berl). 2006;84:478-483.
95. Matsumoto Y, Hayashi T, Inagaki N, Takahashi M, Hiroi S, Nakamura T, Arimura T, Nakamura K, Ashizawa N, Yasunami M, Ohe T, Yano K, Kimura A. Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy. J Muscle Res Cell Motil. 2005;26:367-374.
96. Carmignac V, Salih MA, Quijano-Roy S, et al. C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. Ann Neurol. 2007;61:340-351.
97. Arimura T, Bos JM, Sato A, Kubo T, Okamoto H, Nishi H, Harada H, Koga Y, Moulik M, Doi YL, Towbin JA, Ackerman MJ, Kimura A. Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardio-myopathy. J Am Coll Cardiol. 2009;54:334-342.
98. Peled Y, Gramlich M, Yoskovitz G, et al. Titin mutation in familial restrictive cardiomyopathy. Int J Cardiol. 2014;171:24-30.
99. Taylor M, Graw S, Sinagra G, et al. Genetic variation in titin in ar-rhythmogenic right ventricular cardiomyopathy-overlap syndromes. Circulation. 2011;124:876-885.
100. Anderson BR, Bogomolovas J, Labeit S, Granzier H. Single molecule force spectroscopy on titin implicates immunoglobulin domain stability as a cardiac disease mechanism. J Biol Chem. 2013;288:5303-5315.
101. Golbus JR, Puckelwartz MJ, Fahrenbach JP, Dellefave-Castillo LM, Wolfgeher D, McNally EM. Population-based variation in cardiomyopa-thy genes. Circ Cardiovasc Genet. 2012;5:391-399.
102. Gramlich M, Michely B, Krohne C, Heuser A, Erdmann B, Klaassen S, Hudson B, Magarin M, Kirchner F, Todiras M, Granzier H, Labeit S, Thierfelder L, Gerull B. Stress-induced dilated cardiomyopathy in a knock-in mouse model mimicking human titin-based disease. J Mol Cell Cardiol. 2009;47:352-358.
103. Cazorla O, Freiburg A, Helmes M, Centner T, McNabb M, Wu Y, Trombitás K, Labeit S, Granzier H. Differential expression of cardiac titin isoforms and modulation of cellular stiffness. Circ Res. 2000;86:59-67.
104. Neagoe C, Opitz CA, Makarenko I, Linke WA. Gigantic variety: expression patterns of titin isoforms in striated muscles and consequences for myofbrillar passive stiffness. J Muscle Res Cell Motil. 2003;24:175-189.
105. Neagoe C, Kulke M, del Monte F, Gwathmey JK, de Tombe PP, Hajjar RJ, Linke WA. Titin isoform switch in ischemic human heart disease. Circulation. 2002;106:1333-1341.
106. Opitz CA, Leake MC, Makarenko I, Benes V, Linke WA. Developmentally regulated switching of titin size alters myofbrillar stiffness in the perinatal heart. Circ Res. 2004;94:967-975.
107. Lahmers S, Wu Y, Call DR, Labeit S, Granzier H. Developmental control of titin isoform expression and passive stiffness in fetal and neonatal myocardium. Circ Res. 2004;94:505-513.
108. Warren CM, Krzesinski PR, Campbell KS, Moss RL, Greaser ML. Titin isoform changes in rat myocardium during development. Mech Dev. 2004;121:1301-1312.
109. Makarenko I, Opitz CA, Leake MC, Neagoe C, Kulke M, Gwathmey JK, del Monte F, Hajjar RJ, Linke WA. Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopa-thy hearts. Circ Res. 2004;95:708-716.
110. Nagueh SF, Shah G, Wu Y, Torre-Amione G, King NM, Lahmers S, Witt CC, Becker K, Labeit S, Granzier HL. Altered titin expression, myocar-dial stiffness, and left ventricular function in patients with dilated cardio-myopathy. Circulation. 2004;110:155-162.
111. Borbély A, Falcao-Pires I, van Heerebeek L, Hamdani N, Edes I, Gavina C, Leite-Moreira AF, Bronzwaer JG, Papp Z, van der Velden J, Stienen GJ, Paulus WJ. Hypophosphorylation of the stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res. 2009;104:780-786.
112. Falcão-Pires I, Hamdani N, Borbély A, Gavina C, Schalkwijk CG, van der Velden J, van Heerebeek L, Stienen GJ, Niessen HW, Leite-Moreira AF, Paulus WJ. Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and car-diomyocyte stiffness. Circulation. 2011;124:1151-1159.
113. Williams L, Howell N, Pagano D, Andreka P, Vertesaljai M, Pecor T, Frenneaux M, Granzier H. Titin isoform expression in aortic stenosis. Clin Sci (Lond). 2009;117:237-242.
114. Hudson B, Hidalgo C, Saripalli C, Granzier H. Hyperphosphorylation of mouse cardiac titin contributes to transverse aortic constriction-induced diastolic dysfunction. Circ Res. 2011;109:858-866.
115. Wu Y, Peng J, Campbell KB, Labeit S, Granzier H. Hypothyroidism leads to increased collagen-based stiffness and re-expression of large cardiac titin isoforms with high compliance. J Mol Cell Cardiol. 2007;42:186-195.
116. Shapiro BP, Lam CS, Patel JB, Mohammed SF, Kruger M, Meyer DM, Linke WA, Redfeld MM. Acute and chronic ventricular-arterial coupling in systole and diastole: insights from an elderly hypertensive model. Hypertension. 2007;50:503-511.
117. Hamdani N, Bishu KG, von Frieling-Salewsky M, Redfeld MM, Linke WA. Deranged myoflament phosphorylation and function in experimental heart failure with preserved ejection fraction. Cardiovasc Res. 2013;97:464-471.
118. Warren CM, Jordan MC, Roos KP, Krzesinski PR, Greaser ML. Titin isoform expression in normal and hypertensive myocardium. Cardiovasc Res. 2003;59:86-94.
119. Wu Y, Bell S P, Trombitas K, Witt CC, Labeit S, LeWinter MM, Granzier H. Changes in titin isoform expression in pacing-induced cardiac failure give rise to increased passive muscle stiffness. Circulation. 2002;106:1384-1389.
120. Jaber WA, Maniu C, Krysiak J, Shapiro BP, Meyer DM, Linke WA, Redfeld MM. Titin isoforms, extracellular matrix, and global chamber remodeling in experimental dilated cardiomyopathy: functional implications and mechanistic insight. Circ Heart Fail. 2008;1:192-199.
121. Chaturvedi RR, Herron T, Simmons R, Shore D, Kumar P, Sethia B, Chua F, Vassiliadis E, Kentish JC. Passive stiffness of myocardium from congenital heart disease and implications for diastole. Circulation. 2010;121:979-988.
122. Rain S, Handoko ML, Trip P, et al. Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation. 2013;128:2016-2025.
123. Kötter S, Gout L, Von Frieling-Salewsky M, Müller AE, Helling S, Marcus K, Dos Remedios C, Linke WA, Krüger M. Differential changes in titin domain phosphorylation increase myoflament stiffness in failing human hearts. Cardiovasc Res. 2013;99:648-656.
124. Hoskins AC, Jacques A, Bardswell SC, McKenna WJ, Tsang V, dos Remedios CG, Ehler E, Adams K, Jalilzadeh S, Avkiran M, Watkins H, Redwood C, Marston SB, Kentish JC. Normal passive viscoelasticity but abnormal myofbrillar force generation in human hypertrophic cardio-myopathy. J Mol Cell Cardiol. 2010;49:737-745.
125. Hamdani N, Franssen C, Lourenço A, et al. Myocardial titin hypophos-phorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model. Circ Heart Fail. 2013;6:1239-1249.
126. Krüger M, Sachse C, Zimmermann WH, Eschenhagen T, Klede S, Linke WA. Thyroid hormone regulates developmental titin isoform transitions via the phosphatidylinositol-3-kinase/AKT pathway. Circ Res. 2008;102:439-447.
127. Krüger M, Babicz K, von Frieling-Salewsky M, Linke WA. Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy. J Mol Cell Cardiol. 2010;48:910-916.
128. Li S, Guo W, Dewey CN, Greaser ML. Rbm20 regulates titin alternative splicing as a splicing repressor. Nucleic Acids Res. 2013;41:2659-2672.
129. Guo W, Schafer S, Greaser ML, et al. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med. 2012;18:766-773.
130. Linke WA, Bücker S. King of hearts: a splicing factor rules cardiac proteins. Nat Med. 2012;18:660-661.
131. Huttlin EL, Jedrychowski MP, Elias JE, Goswami T, Rad R, Beausoleil SA, Villén J, Haas W, Sowa ME, Gygi SP. A tissue-specifc atlas of mouse protein phosphorylation and expression. Cell. 2010;143:1174-1189.
132. Lundby A, Secher A, Lage K, Nordsborg NB, Dmytriyev A, Lundby C, Olsen J V. Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues. Nat Commun. 2012;3:876.
133. Gautel M, Leonard K, Labeit S. Phosphorylation of KSP motifs in the C-terminal region of titin in differentiating myoblasts. EMBO J. 1993;12:3827-3834.
134. Sebestyén MG, Wolff JA, Greaser ML. Characterization of a 5.4 kb cDNA fragment from the Z-line region of rabbit cardiac titin reveals phosphorylation sites for proline-directed kinases. J Cell Sci. 1995;108(Pt 9):3029-3037.
135. Gautel M, Goulding D, Bullard B, Weber K, Fürst DO. The central Z-disk region of titin is assembled from a novel repeat in variable copy numbers. J Cell Sci. 1996;109(Pt 11):2747-2754.
136. Yamasaki R, Wu Y, McNabb M, Greaser M, Labeit S, Granzier H. Protein kinase A phosphorylates titin's cardiac-specifc N2B domain and reduces passive tension in rat cardiac myocytes. Circ Res. 2002;90:1181-1188.
137. Fukuda N, Wu Y, Nair P, Granzier HL. Phosphorylation of titin modulates passive stiffness of cardiac muscle in a titin isoform-dependent manner. J Gen Physiol. 2005;125:257-271.
138. Leake MC, Grützner A, Krüger M, Linke WA. Mechanical properties of cardiac titin's N2B-region by single-molecule atomic force spectroscopy. J Struct Biol. 2006;155:263-272.
139. Krüger M, Linke WA. Protein kinase-A phosphorylates titin in human heart muscle and reduces myofbrillar passive tension. J Muscle Res Cell Motil. 2006;27:435-444.
140. Krüger M, Kötter S, Grützner A, Lang P, Andresen C, Redfeld MM, Butt E, dos Remedios CG, Linke WA. Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ Res. 2009;104:87-94.
141. Raskin A, Lange S, Banares K, Lyon RC, Zieseniss A, Lee LK, Yamazaki KG, Granzier HL, Gregorio CC, McCulloch AD, Omens JH, Sheikh F. A novel mechanism involving four-and-a-half LIM domain protein-1 and extracellular signal-regulated kinase-2 regulates titin phosphorylation and mechanics. J Biol Chem. 2012;287:29273-29284.
142. Hamdani N, Krysiak J, Kreusser MM, Neef S, Dos Remedios CG, Maier LS, Krüger M, Backs J, Linke WA. Crucial role for Ca2(+)/calmodulin-dependent protein kinase-II in regulating diastolic stress of normal and failing hearts via titin phosphorylation. Circ Res. 2013;112:664-674.
143. Hidalgo CG, Chung CS, Saripalli C, Methawasin M, Hutchinson KR, Tsaprailis G, Labeit S, Mattiazzi A, Granzier HL. The multifunctional Ca(2+)/calmodulin-dependent protein kinase II delta (CaMKIIδ) phosphorylates cardiac titin's spring elements. J Mol Cell Cardiol. 2013;54:90-97.
144. Hidalgo C, Hudson B, Bogomolovas J, Zhu Y, Anderson B, Greaser M, Labeit S, Granzier H. PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness. Circ Res. 2009;105:631-638.
145. Krüger M, Moser M, Ussar S, Thievessen I, Luber CA, Forner F, Schmidt S, Zanivan S, Fässler R, Mann M. SILAC mouse for quantitative pro-teomics uncovers kindlin-3 as an essential factor for red blood cell function. Cell. 2008;134:353-364.
146. Hamdani N, de Waard M, Messer AE, et al. Myoflament dysfunction in cardiac disease from mice to men. J Muscle Res Cell Motil. 2008;29:189-201.
147. Linke WA, Grützner A. Pulling single molecules of titin by AFM-recent advances and physiological implications. Pfugers Arch. 2008;456:101-115.
148. Couchonnal LF, Anderson ME. The role of calmodulin kinase II in myo-cardial physiology and disease. Physiology (Bethesda). 2008;23:151-159.
149. van Heerebeek L, Hamdani N, Falcão-Pires I, Leite-Moreira AF, Begieneman MP, Bronzwaer JG, van der Velden J, Stienen GJ, Laarman GJ, Somsen A, Verheugt FW, Niessen HW, Paulus WJ. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation. 2012;126:830-839.
150. Bishu K, Hamdani N, Mohammed SF, Kruger M, Ohtani T, Ogut O, Brozovich F V, Burnett JC Jr, Linke WA, Redfeld MM. Sildenafl and B-type natriuretic peptide acutely phosphorylate titin and improve dia-stolic distensibility in vivo. Circulation. 2011;124:2882-2891.
151. Zhang R, Khoo MS, Wu Y, et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat Med. 2005;11:409-417.
152. Grützner A, Garcia-Manyes S, Kötter S, Badilla CL, Fernandez JM, Linke WA. Modulation of titin-based stiffness by disulfde bonding in the cardiac titin N2-B unique sequence. Biophys J. 2009;97:825-834.
153. Alegre-Cebollada J, Kosuri P, Giganti D, Eckels E, Rivas-Pardo A, Hamdani N, Warren CM, Solaro RJ, Linke WA, Fernández JM. S-glutathionylation of cryptic cysteines enhances titin elasticity by blocking protein folding. Cell. http://dx.doi.org/10.1016/j.cell.2014.01.056.
154. Zhang M, Kass DA. Phosphodiesterases and cardiac cGMP: evolving roles and controversies. Trends Pharmacol Sci. 2011;32:360-365.
155. Kuhn M. Molecular physiology of natriuretic peptide signalling. Basic Res Cardiol. 2004;99:76-82.
156. Boerrigter G, Costello-Boerrigter LC, Cataliotti A, Lapp H, Stasch JP, Burnett JC Jr. Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure. Hypertension. 2007;49:1128-1133.